(MedPage Today) — Supplemental use of multi-cancer early detection (MCED) testing has the potential to substantially reduce late-stage cancer diagnoses, according to results from a modeling study.
Over the course of 10 years, use of annual supplemental…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/118477
Author :
Publish date : 2025-11-12 18:57:00
Copyright for syndicated content belongs to the linked Source.
